Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

12,272 total articles

Nano Dimension Signs Term Sheet with Infinite Epigenetics to Form a Publicly Traded, AI-Powered Preventive Health and Diagnostics Company

Nano Dimension Signs Term Sheet with Infinite Epigenetics to Form a Publicly Traded, AI-Powered Preventive Health and Diagnostics Company

Nano Dimension Ltd. (Nasdaq: NNDM) announced a non-binding term sheet to combine with Infinite Epigenetics, an AI-powered preventive health and diagnostics company. The transaction will leverage Nano Dimension's Nasdaq listing and capital to accelerate growth in the healthcare AI sector. Infinite Epigenetics focuses on epigenetic diagnostics target…

Anfield Energy Announces a Key Milestone in Equipment Procurement, Advancing the Company Towards Hub-and-Spoke Production

Anfield Energy Announces a Key Milestone in Equipment Procurement, Advancing the Company Towards Hub-and-Spoke Production

Anfield Energy Inc. received the first custom-built underground haul truck from Young’s Machine Company, marking a key milestone in its equipment procurement program. This delivery supports the company’s uranium-vanadium mining operations in Utah and Colorado, advancing production under its hub-and-spoke model. Additionally, Anfield secured a new a…

Dyadic Highlights Accelerated Interest in C1 Biomanufacturing Platform Amid Ebola Preparedness Activities and Growing Commercial Adoption

Dyadic Highlights Accelerated Interest in C1 Biomanufacturing Platform Amid Ebola Preparedness Activities and Growing Commercial Adoption

Dyadic International highlights growing interest in its proprietary C1 protein production platform driven by intensified Ebola virus outbreak preparedness and expanding commercial adoption across multiple markets. The platform's rapid development capabilities support expedited vaccine antigen and monoclonal antibody production, aligning with global…

Elicio Therapeutics Reports Results from Phase 2 AMPLIFY-7P Study and Outlines Refined Phase 3 Development Strategy for ELI-002 7P in Adjuvant Pancreatic Cancer

Elicio Therapeutics Reports Results from Phase 2 AMPLIFY-7P Study and Outlines Refined Phase 3 Development Strategy for ELI-002 7P in Adjuvant Pancreatic Cancer

Elicio Therapeutics announced that its Phase 2 AMPLIFY-7P study of ELI-002 7P immunotherapy in adjuvant mKRAS-driven pancreatic cancer did not meet the primary disease-free survival endpoint in the intent-to-treat population. However, post-hoc analyses revealed a significant benefit in patients with R0 resection, who represent the majority of the s…

Seer Board of Directors Issues Letter to Shareholders Highlighting the Company’s Significant Scientific Progress and Addressing Radoff and Torok’s Short-Sighted Campaign

Seer Board of Directors Issues Letter to Shareholders Highlighting the Company’s Significant Scientific Progress and Addressing Radoff and Torok’s Short-Sighted Campaign

Seer, Inc.'s Board of Directors has issued a letter to shareholders ahead of the July 28, 2026 Annual Meeting, urging a vote in favor of the current board slate amid activist investor attempts to replace directors and push for a sale. The letter highlights Seer's pioneering leadership in proteomics technology, ongoing large-scale scientific studies…

Axsome Therapeutics Presents New Data Highlighting its Innovative Sleep Medicine Portfolio at SLEEP 2026

Axsome Therapeutics Presents New Data Highlighting its Innovative Sleep Medicine Portfolio at SLEEP 2026

Axsome Therapeutics presented new clinical data on its sleep disorder medicines AXS-12 and solriamfetol at SLEEP 2026, highlighting positive cognitive, functional, and quality-of-life outcomes in narcolepsy and obstructive sleep apnea patients. These presentations reinforce Axsome's leadership in central nervous system disorder treatments and its i…

Lexeo Therapeutics Announces Regulatory Update and Registrational Trial Design for LX2006 Gene Therapy in Friedreich Ataxia

Lexeo Therapeutics Announces Regulatory Update and Registrational Trial Design for LX2006 Gene Therapy in Friedreich Ataxia

Lexeo Therapeutics announced the finalization of the SUNRISE-FA 2 pivotal trial protocol and statistical plan for its gene therapy candidate LX2006 in treating Friedreich Ataxia cardiomyopathy. The open-label study aims to support a Biologics License Application to the FDA under the accelerated approval pathway targeted for 2028. Enrollment is on t…

USA Rare Earth Commissions Hydrometallurgical Demonstration Facility, Targeting Heavy Rare Earth Oxide Production in Third Quarter 2026

USA Rare Earth Commissions Hydrometallurgical Demonstration Facility, Targeting Heavy Rare Earth Oxide Production in Third Quarter 2026

USA Rare Earth, Inc. (Nasdaq: USAR) has commissioned its hydrometallurgical demonstration facility in Wheat Ridge, Colorado, targeting first production of separated heavy rare earth oxides such as dysprosium, terbium, and yttrium by the third quarter of 2026. This marks a significant step toward building a fully integrated rare earth supply chain o…

Natural Gas Services Group Acquires Flatrock Compression

Natural Gas Services Group Acquires Flatrock Compression

Natural Gas Services Group, Inc. (NYSE: NGS) announced the $120 million acquisition of Flatrock Compression Holdings, expanding its rental compression services with additional large horsepower and electric motor units primarily in the Permian Basin and Eagle Ford regions. The acquisition diversifies NGS's customer base, increases operational densit…

ROMA Green Finance to Invest US$15 Million in BlueFlare Group Holdings Inc., Owner of BlueFlare Energy Solutions, Targeting the Underserved Sub-10 MW Segment of a Data-Center Buildout Forecast to Exceed US$3 Trillion This Decade

ROMA Green Finance to Invest US$15 Million in BlueFlare Group Holdings Inc., Owner of BlueFlare Energy Solutions, Targeting the Underserved Sub-10 MW Segment of a Data-Center Buildout Forecast to Exceed US$3 Trillion This Decade

ROMA Green Finance Limited has signed a non-binding letter of intent to invest US$15 million for a 5% equity stake in BlueFlare Group Holdings Inc., a developer of behind-the-meter power generation and distributed compute infrastructure focused on sub-10 MW data centers. This strategic investment is ROMA's first under its new AI/HPC infrastructure …

Aurora Mobile’s Modellix Launches Vidu Q3-Mix to Enhance Content Production Efficiency Across Advertising, E-Commerce, and AI Drama

Aurora Mobile’s Modellix Launches Vidu Q3-Mix to Enhance Content Production Efficiency Across Advertising, E-Commerce, and AI Drama

Aurora Mobile Limited has integrated Vidu Q3-Mix, a new video generation model developed by ShengShu Technology, into its Modellix unified AI media platform. The Vidu Q3-Mix enhances AI-driven video content creation with improved stability, camera control, and multi-character dialogue support, targeting sectors like advertising, e-commerce, AI dram…